Arnold Bloch Leibler has advised Neuren Pharmaceuticals on its latest capital raising. Neuren Pharmaceuticals (ASX: NEU) has completed a placement of new shares to institutional and sophisticated...
Arnold Bloch Leibler has advised Neuren Pharmaceuticals on its latest capital raising. Neuren Pharmaceuticals (ASX: NEU) has completed a placement of new shares to institutional and sophisticated...
You must be a Standard 1 Year member to access this content.